EUVIMEDEUVIMED entdecken
Systematische Übersicht

Combating antimicrobial-resistant Helicobacter pylori infection using nanotechnology- an advancement in gastrointestinal disease treatment

Syed Ali Raza Shah, Muzna Kashif, Shamshul Ansari, Imtiaz Mustafa, Sumaira Sharif, Iffat Nayila, Hafsa Jamil, Nirmal Choudhary

Microbial Pathogenesis · 2026-07 · 216 · 108503

DOI: 10.1016/j.micpath.2026.108503 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Microbial Pathogenesis, 2026-07. Verfasst von Syed Ali Raza Shah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan. Electronic address: ali.raza@imbb.uol.edu.pk. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Anti-Bacterial Agents, Nanotechnology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Helicobacter pylori (H. pylori) is a worldwide pathogen associated with chronic gastritis, peptic ulcers, and a high risk of developing gastric cancers. The lack of conventional treatments due to increasing antimicrobial resistance has turned this into an urgent crisis call for alternative approaches. Nanoparticles can be engineered to encapsulate antimicrobial peptides that will release their therapeutic payloads and thus target H. pylori more specifically while preserving beneficial microbiota. STUDY AIMS: This systematic review scrutinized nanoparticle-based therapeutics for H. pylori, including recent progress in metallic, polymeric, lipidic, and hybrid nanoparticle approaches regarding mechanisms, efficacy, and safety. Given the emergence of nanotechnology as a promising solution, nanoparticles provide targeted delivery, biofilm disruption, and bactericidal effects. METHODS: In this study, we conducted a systematic literature review from 2013 to 2026 for the articles published in PubMed, Web of Science, Scopus, and Google Scholar. The articles related to the application of nanoparticles for H. pylori treatments were included. Key data on nanoparticle types, mechanisms, efficacy, biofilm penetration, and cytotoxicity were extracted and analyzed. High eradication rates (over 90%) were achieved with reactive oxygen species generation and membrane disruption by metallic nanoparticles, especially silver and gold. CONCLUSION: Targeted drug release with reduced side effects was achieved using polymeric nanoparticles such as chitosan, and polylactic-co-glycolic acid (PLGA). Stability and biocompatibility were achieved using nanoparticles that provided the ability to introduce multiple agents for synergistic therapeutic impact. For H. pylori-resistant cases, nanoparticle-based therapies could be a potential alternative treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsAnti-Bacterial AgentsNanotechnologyDrug Resistance, BacterialGastrointestinal DiseasesHumansBiofilmsNanoparticlesMetal NanoparticlesAntimicrobial PeptidesDrug Delivery Systems

Stichwörter der Autor:innen

Anti-bacterialAntimicrobial resistanceBiofilm disruptionHelicobacter pyloriInhibitorsNanoparticle therapyNanotechnologyReactive oxygen species

Substanzen

Anti-Bacterial AgentsAntimicrobial Peptides

Autor:innen und Institutionen

  • Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan. Electronic address: ali.raza@imbb.uol.edu.pk.
  • Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan.
  • Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu, 879-5593, Japan; Health Science Division, Higher Colleges of Technology, Abu Dhabi Campus, Abu Dhabi, 25026, United Arab Em…
  • Department of Pharmacy, The University of Lahore, Sargodha Campus, Pakistan.

Förderung

  • Japan Agency for Medical Research and Development
  • Japan International Cooperation Agency
  • Science and Technology Research Partnership for Sustainable Development

Zitieren

APA

Shah, S. A. R., Kashif, M., Ansari, S., Mustafa, I., Sharif, S., Nayila, I., Jamil, H., & Choudhary, N. (2026). Combating antimicrobial-resistant Helicobacter pylori infection using nanotechnology- an advancement in gastrointestinal disease treatment. Microbial Pathogenesis, 216, 108503. https://doi.org/10.1016/j.micpath.2026.108503

Vancouver

Shah SAR, Kashif M, Ansari S, Mustafa I, Sharif S, Nayila I, et al. Combating antimicrobial-resistant Helicobacter pylori infection using nanotechnology- an advancement in gastrointestinal disease treatment. Microbial Pathogenesis. 2026;216:108503. doi:10.1016/j.micpath.2026.108503

BibTeX
@article{Shah2026,
  author = {Shah, Syed Ali Raza and Kashif, Muzna and Ansari, Shamshul and Mustafa, Imtiaz and Sharif, Sumaira and Nayila, Iffat and Jamil, Hafsa and Choudhary, Nirmal},
  title = {Combating antimicrobial-resistant Helicobacter pylori infection using nanotechnology- an advancement in gastrointestinal disease treatment},
  journal = {Microbial Pathogenesis},
  year = {2026},
  volume = {216},
  pages = {108503},
  doi = {10.1016/j.micpath.2026.108503}
}
Kostenlos starten →